CSL’s new headquarters in Australia officially opened in last month, placing the global company in the good company of in Melbourne’s Biomedical Precinct. More than 850 employees will work in the building, which includes seven floors of lab space, a 150-seat auditorium and 60+ meeting rooms. It’s also home to the Jumar Bioincubator, a multi-partner collaboration providing office and lab space for up to 40 biotech start-ups.
CSL, founded in 1916, includes business units CSL Behring, which makes medicines for people who have rare and serious diseases; CSL Seqirus, which develops and manufactures vaccines; and CSL Vifor, a leader in iron deficiency and nephrology (kidney care). CSL also operates CSL Plasma, one of the largest collectors of donated human plasma used to make medicines for diseases such as hemophilia and primary immune deficiency.
